fbpx

WA’s leading pharmacists named in PSA Awards

14 April 2025

 

The Pharmaceutical Society of Australia (PSA) has presented its 2025 Western Australia Pharmacy Awards, recognising the pharmacists going above and beyond to deliver better care for their communities.

 

As the peak body for pharmacists, PSA awards pharmacists who make significant contributions to the pharmacy profession through their leadership, commitment to patient care, and excellence in practice.

 

The pharmacists named in the 2025 West Australian Pharmacy Awards are:

  • Ashleigh Chapman MPS as PSA West Australian Pharmacist of the Year
  • Rhiannon Price MPS as PSA West Australian Early Career Pharmacist of the Year
  • Rachel Lawson MPS as PSA West Australian Intern Pharmacist of the Year
  • Emeritus Professor Jeff Hughes FPS as recipient of the PSA West Australian Lifetime Achievement Award.

 

PSA WA President Kristian Ray MPS congratulated recipients.

 

“West Australian pharmacists are stepping up across our health system – I’m proud to recognise and celebrate their impact” Mr Ray said.

 

“Our WA award winners do themselves and their profession proud and are exceptionally worthy recipients. On behalf of the entire PSA community, congratulations to Ash, Rhiannon, Rachel and Jeff.”

 

About our winners:


Ashleigh Chapman – PSA WA Pharmacist of the Year

 

Ashleigh Chapman is an outstanding pharmacist whose leadership, innovation, and commitment to patient-centred care have improved medicines stewardship, and equitable access to care in her community. As a non-dispensing General Practice pharmacist at View Street Medical in North Perth, Ash is a driving force in service innovation, improving measurable health outcomes for vulnerable populations and assisting patients in managing chronic disease.

 

Ash plays an essential role in ensuring medicine safety, conducting comprehensive medication reviews, identifying and managing drug interactions, and leading practice-wide quality improvement initiatives. Her audits on chronic kidney disease and RSV vaccine eligibility have directly contributed to enhanced patient care, with further initiatives planned to support cardiovascular health.

 

Her leadership in medicines stewardship extends to overseeing practice medication stocktake and ordering, as well as managing long-acting injectable HIV medications at the Cabenuva clinic.

 

Ash’s coordination of the long-acting injectable HIV medication clinic exemplifies her commitment to equity and access to care. By enabling individuals to receive their treatment in a general practice setting instead of a hospital, she reduces barriers to care and stigma.

 

This initiative directly contributes to Western Australia’s progress toward the WHO’s “95-95-95” HIV targets. Additionally, her work at Casson House support individuals with complex mental health needs, while her work with gender-affirming healthcare ensures that high-risk patients receive the care they need with dignity and support.

 

A dedicated mentor, Ash actively shares her expertise with GP registrars, medical students, and nurses. Her presentation at the General Practice Pharmacist Symposium in March further highlights her contributions to the profession.

 

For her unwavering dedication to improving patient outcomes, advancing pharmacy practice, and fostering workforce development, Ashleigh Chapman is a highly deserving recipient of the PSA WA Pharmacist of the Year award.

 

Rhiannon Price MPS – PSA WA Early Career Pharmacist of the Year

 

Rhiannon is an innovative and dedicated pharmacist whose contributions to Aboriginal and Torres Strait Islander care and pharmacy practice are improving patient outcomes. As a General Practice pharmacist at Derbarl Yerrigan Health Service in Maddington, she has led initiatives that enhance health literacy, improve chronic disease management, and advance the role of pharmacists in both primary and aged care settings. Rhiannon also works as a clinical pharmacist at King Edward Memorial Hospital.

 

A leader in clinical service innovation, Rhiannon has implemented a pharmacist-led spirometry service, supporting early diagnosis and management of respiratory conditions such as asthma and COPD. She has also introduced continuous glucose monitoring, empowering patients to better understand and manage their diabetes while using this as an educational tool to strengthen health literacy. Her ability to foster trust and build strong relationships within the community ensures a culturally safe healthcare environment for First Nations people.

 

Beyond her clinical work, Rhiannon is shaping the future of pharmacy practice. She was named a 2024 Advancing Practice Pioneer by the Australian Journal of Pharmacy in recognition of her leadership in Aboriginal healthcare. Her work on the aged care on-site pharmacist (ACOP) model, incorporating expert and consumer feedback into a key policy paper, demonstrates her commitment to workforce development and the future of aged care pharmacy. Additionally, she has contributed to PSA’s educational package, supporting pharmacists in delivering high-quality travel health consultations.

 

Rhiannon’s expertise, compassionate communication, and commitment to culturally responsive care make her a valued member of her healthcare team. Her passion for patient-centred care and ability to drive meaningful change position her as a role model for early career pharmacists. For her leadership, innovation, and dedication to improving health outcomes, Rhiannon is a deserving recipient of the PSA WA Early Career Pharmacist of the Year award.

 

Rachel Lawson – PSA WA Intern Pharmacist of the Year

 

Rachel Lawson has demonstrated exceptional dedication to patient-centred care, health promotion, and harm reduction throughout her internship, making a significant impact on both her pharmacy team and the wider community.

 

Committed to integrating preventative health strategies into pharmacy practice, Rachel played a key role in training colleagues on initiating health-focused conversations with patients. Having worked in multiple pharmacy roles over six years, she fostered a positive and empowering team environment, supporting staff across all levels.

 

Rachel’s leadership in harm reduction was evident in her advocacy for the Take Home Naloxone program, where she developed consumer-friendly resources and staff training to improve naloxone accessibility, reducing the risk of opioid overdose. She also introduced innovative services, including HIV Self Testing within the pharmacy and a COPD risk screening pilot using the Vitalograph COPD-6 device. Her coordination of bone health clinics further showcased her commitment to preventative healthcare.

 

Beyond service delivery, Rachel actively engaged with her peers and community. She led a high-impact sleep health presentation for over 150 community members, collaborating with a local researcher to raise awareness of sleep disorders and management options.

 

Rachel’s proactive mindset, leadership, and commitment to public health make her a highly deserving recipient of the PSA WA Intern Pharmacist of the Year award.

 

Emeritus Professor Jeff Hughes FPS – PSA WA Lifetime Achievement Award Recipient

 

Emeritus Professor Jeff Hughes is recognised with the PSA WA Lifetime Achievement Award for his outstanding 45-year career in pharmacy, spanning clinical practice, education, and research, including as PSA’s National Vice-President from 2015 to 2016. His contributions have shaped the profession and left a lasting impact on patient care, pharmacy education, and medication management.

 

Beginning his career as a hospital pharmacist in 1980, Jeff played a pioneering role in advancing clinical pharmacy practice in Australia. As the leader of Clinical Pharmacy Services at Sir Charles Gairdner Hospital in Nedlands, he was instrumental in integrating pharmacists into patient care teams. He later led the Western Australian Antibiotic Guidelines Review Committee, a critical initiative in improving medicine safety across the state.

 

Transitioning to academia in 1997, Jeff’s influence expanded as he shaped the education of future pharmacists at Curtin University. His leadership led to the establishment of the Australasian Clinical Pharmacy Education seminars, which have enhanced pharmacists’ skills in medication management. Under his tenure as Head of Curtin’s School of Pharmacy, the school’s research output tripled, and its global ranking significantly improved.

 

A prolific researcher, Jeff has secured $14 million in research grants and published 176 refereed journal articles on critical issues such as hypertension, diabetes management, and medication transitions. His collaborations with national and international institutions have further strengthened the field of pharmacy research.

 

He is currently the Chief Scientific Officer of PainChek Ltd which is commercialising AI based pain assessment tools that he co-invented.

 

Jeff’s legacy is one of excellence, leadership, and dedication to advancing pharmacy practice. His contributions have shaped clinical education, policy, and research, making him a truly deserving recipient of the PSA WA Lifetime Achievement Award.

 

​Photos of the winners are available on request.

 

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

PSA welcomes re-elected Cook Government and commitment to expanding WA pharmacists’ scope of practice

14 March 2025

 

The Pharmaceutical Society of Australia (PSA) congratulates the Western Australian Government on its re-election and welcomes its ongoing commitment to strengthening the role of pharmacists in delivering accessible healthcare to the community.

 

PSA Western Australia President Kristian Ray MPS said the Cook Government’s continued support for pharmacist-led care was a step forward in improving access to timely treatment and reducing pressure on the broader health system.

 

“The West Australian Government has demonstrated a clear commitment to enhancing the role of pharmacists as frontline healthcare professionals, ensuring that Western Australians can access essential care when and where they need it,” Mr Ray said.

 

“The expanded scope of practice pilot is a significant investment in expanding pharmacists’ scope of practice and will enable pharmacists to deliver more accessible primary healthcare services across the state.

 

“We particularly note the Government’s ongoing support for pharmacist prescribing initiatives, including treatment for uncomplicated urinary tract infections, resupply of oral contraceptives, and expanding pharmacists’ vaccination scope.

 

“These initiatives recognise the vital role pharmacists play in delivering timely and accessible care, particularly for rural and regional communities where access to GPs can be challenging.”

 

Mr Ray reaffirmed PSA’s commitment to supporting pharmacists as they step up to meet the evolving healthcare needs of the community.

 

“As the peak national body representing all pharmacists, PSA looks forward to working closely with the WA Government to ensure pharmacists are supported with the appropriate training, resources, and recognition to provide these essential services safely and effectively.

 

“We will continue to advocate for the sustainable integration of pharmacists into the wider health system, ensuring patients can access the right level of care when and where they need it,” Mr Ray concluded.

 

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

WA pharmacists to expand oral contraceptive access

28 May 2024

 

Western Australian pharmacists are set to be able to resupply oral contraceptives to women across the state as part of a new pilot program.

The Pharmacist Resupply of Oral Contraceptive Pills Pilot enables pharmacists to supply up to 12 months of a combination or progestogen-only contraceptive pill to women* between 18 and 39 years of age who have a stable history of using the pill for two years. Patients aged between 16 and 17 years can access up to four months’ supply as an extension to their original prescription.

Pharmacists are required to undergo additional training before commencing services.

 

Pharmaceutical Society of Australia (PSA) WA President Kristian Ray welcomed the Pilot announcement.

“WA has now joined the majority of Australian states and territories giving women greater autonomy and choice when it comes to accessing oral contraceptives,” Mr Ray said.

“It shows how pharmacists working together with GPs and other healthcare professionals can improve the care we provide, relieving strain on our healthcare systems in a safe and efficient way.

 

“This is a step forward, ensuring that reproductive care is accessible and safe.

“We applaud the Cook Government’s initiation of this pilot, recognising not only pharmacist’s role as medicine safety experts, but also underscoring the importance of a collaborative, patient-centred approach to healthcare delivery.”

With compulsory training now available, Mr Ray encouraged pharmacists across the state to take up the opportunity.

“The oral contraceptive pilot is a new opportunity for pharmacists to develop new skills, underpinned by quality education and training and best-practice care.

“The oral contraceptive pilot isn’t just about expanding our scope of practice, it’s about ensuring that every individual receives the care and support they need to make informed decisions about their reproductive health,” Mr Ray concluded.

 

*Pharmacists providing contraception and sexual health advice for transgender and gender diverse individuals presumed female at birth must ensure the service is safe and accessible. It’s important to verify that transgender and gender diverse individuals seeking contraceptive care are actively engaged with appropriate sexual health services as needed. The resupply of OCP is permitted for transgender and gender diverse individuals, provided all other protocol conditions are met.

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Pharmacists welcome another year of free influenza vaccines in WA Budget

10 May 2024

The Pharmaceutical Society of Australia (PSA) welcomes the 2024-25 Western Australia Budget delivered by Treasurer the Hon. Rita Saffioti MLA yesterday, with a record $3.2 billion investment in health and mental health across the state.


Importantly, the Budget also allocated $8 million for free flu vaccines in May and June 2025 for all Western Australians aged six months and older.


PSA Western Australia President Kristian Ray MPS said that the budget measure provides certainty for the state’s pharmacists.


“Knowing that the Cook Government will provide free influenza vaccines in 2025 gives pharmacists the opportunity to prepare early to meet increased demand,” Mr Ray said.


“Reducing barriers to vaccination is key to improving uptake, including making them low- or no-cost to consumers, and allowing families to get vaccinated together before the flu season begins.


“PSA continues to advocate for the pharmacist immuniser workforce to be fully utilised, delivering all vaccines to patients of all ages and in all settings in line with best practice. This means amending the existing authority and allowing pharmacist to deliver childhood vaccinations, including influenza vaccines, providing Western Australians greater choice and equitable options to access vaccines.


“Pharmacists have demonstrated competency in delivering vaccines safely and effectively and have made a significant contribution to public health by vaccinating countless Western Australians.


“We look forward to continuing our work with the Cook Government to ensure that pharmacists are able to reach their full potential, as immunisers and as health care professionals,” Mr Ray concluded.

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Top West Australian pharmacists recognised

Four outstanding pharmacists have been celebrated this evening as part of the annual Pharmaceutical Society of Australia (PSA) Western Australia Excellence Awards held in Perth.

PSA’s Excellence Awards recognises local pharmacists involved in innovative practice, those who are striving to raise practice standards, and those who, through their professionalism, provide a model of practice which others strive to emulate.

Awards were presented to:

  • Susan Shipway, WA Pharmacist of the Year
  • Maria Luz Ciancia, WA Intern Pharmacist of the Year
  • Jade Swarbrick, WA Early Career Pharmacist of the Year
  • Liza Seubert, WA Lifetime Achievement Award

 

PSA Western Australia President Kristian Ray MPS congratulated the award recipients.

“Pharmacists are making significant contributions to the health sector, and Western Australia is home to some of the best,” Mr Ray said.

“The pharmacists recognised by the PSA Excellence Awards represent the dedication of great pharmacists. We are proud to recognise them for their ongoing contributions to the profession and to the health of their communities.

“On behalf of PSA and all West Australian pharmacists, congratulations to the 2024 award recipients,” Mr Ray concluded.

 

Media notes

The WA Pharmacist of the Year is Susan Shipway

Susan Shipway is a hospital pharmacist at Rockingham General Hospital, specialising in oncology and haematology. She recently established a unique pharmacist-led telehealth remote service to patients living in regional Western Australia as part of a PSA partnered non-dispensing pharmacists in general practice heart failure program with the WA Primary Health Alliance.

Sue has strengthened ties between Midwest Aero and Geraldton Hospital and local specialists, having met with the cardiology team at Geraldton Hospital to improve transitions of care. She has initiated heart failure medication optimisation and titration plans to support the GPs within Midwest Aero Medical to ensure patients with heart failure are receiving optimal treatment for their heart failure. She has also developed heart failure fluid balance plans for patients to self-manage their diuretics.

By utilising telehealth to provide heart failure reviews for patients newly discharged, diagnosed or that have previously been identified as living with heart failure, Sue proactively educate patients about the condition. Investigating how the patient is managing by explaining possible and current symptoms and why patients suffer these, is imperative to practising truly patient-centred care.

This is the first time a remote service has been offered to patients living in a regional area, keeping heart failure patients out of hospital by enabling them to manage their condition more effectively.

The WA Intern Pharmacist of the Year is Maria Luz Ciancia

Maria Luz Ciancia spent five years studying pharmacy in Argentina before making the move to Australia. After undertaking exams to revalidate her degree, Maria undertook her internship with Chemist Warehouse in Perth.

At the end of her intern year, Maria developed a mental health campaign to support people suffering from depression in Western Australia. The campaign focused on assessing risk factors, prevention of adverse medication event, and empowering patients to achieve the best practice in medicines management through the implementation of proven and sustainable strategies integrated across all healthcare settings.

 

The WA Early Career Pharmacist of the Year is Jade Swarbrick

Jade Swarbrick began her pharmacy career as a community pharmacist at Amcal Como after graduating with a Master of Pharmacy in 2018. In 2021 she became credentialed and in 2022 she completed a Graduate Certificate in Clinical Pharmacy at Monash University. Wanting to discover where pharmacy could take her and gain experience in a variety of diverse roles Jade spent time working as a hospital pharmacist at Joondalup Hospital & Northam Hospital, tutoring compounding labs at Curtin University, completing HMRs in community, working in RACFs, and until it’s unfortunate end – working as an educational visitor with NPS MedicineWise.

Since early 2023 Jade has been a GP pharmacist at Mead Medical, as part of the WA Primary Health Alliance non-dispensing pharmacists in general practice program.

She quickly established a pharmacist role at Mead Medical conducting medication reviews as part of chronic disease management appointments; as well as leading several other projects to improve chronic disease management and quality use of medications.

Jade has been recognised in this role as consistently and significantly contributing to improved patient outcomes – and is a highly respected and valued member of the Mead Medical team. She has found her passion in this setting; and is dedicated to advocating for the role of pharmacists in general practice, contributing to the community of practice and helping to mentor pharmacists new to the position.

More recently, Jade has also joined the CoNeCT MHE (Complex Needs Coordination Team – Mental Health Expansion) team as a Care Coordinator. Working with the most frequent emergency department presenters across the Perth-wide hospital services.

Bringing her advanced clinical knowledge, and experience working across the spectrum of healthcare settings she has helped to demonstrate the invaluable role pharmacists can have in multidisciplinary care coordination roles within WA Health.

Between these roles Jade has found her pharmacist niche – providing holistic, patient centred care, optimizing management of patients physical and mental health and advocating for patients experiencing psychosocial barriers to accessing appropriate healthcare.

 

The WA Lifetime Achievement Award is presented to Associate Professor Liza Seubert FPS

Associate Professor Liza Seubert is a respected figure in the pharmacy profession, earning recognition for her unwavering dedication and transformative contributions. With a career spanning several decades, Liza’s journey began in community pharmacy, moving to the Pharmaceutical Council of Western Australia and Ahpra, and finally to academia at the University of Western Australia.

Throughout her career, Liza’s journey has been marked by innovation and leadership. After establishing herself as a pharmacist, she ventured into ownership and introduced pioneering service delivery models at her pharmacy, setting a precedent for personalised care and medication reviews. Her innovative approach garnered praise, with prominent individuals like Premier Geoff Gallop acknowledging her endeavours.

Liza’s impact extends beyond community pharmacy. Recognizing the importance of education and mentorship, she founded Viva Voce tutoring service, fostering confidence and capability in interns for their final oral exams. Her commitment to education led her to roles at the Pharmaceutical Council of Western Australia with the intern training program and later at the University of Western Australia in the Master of Pharmacy program.

At UWA, Liza’s compassion and commitment to social accountability have distinguished her as a true leader. In her 40’s she embarked on a PhD which researched ways to enhance information exchange during over-the-counter consultations while working full time as an academic. Her research has informed curriculum development and accreditation standards nationwide, with further impact in the new PSA Professional Practice Standards and the updated FIP Global Competency Framework.

She has transformed the learning experience of students in the Master of Pharmacy at UWA with an innovative Courage, Connection and Resilience curriculum to graduate pharmacists with the human skills to thrive in the dynamic and evolving pharmacy profession.

Liza represents the Council of Pharmacy Schools of Australia and New Zealand on the steering committee of the Leaders in Indigenous Pharmacy Profession Education (LIPPE) Network. This network is developing pharmacist education to enable culturally safe pharmacy practice.

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

WA pharmacists welcome free influenza vaccine program

3 April 2024

 

The Pharmaceutical Society of Australia (PSA) welcomes the announcement of state-wide free influenza vaccinations for all Western Australians, making it the second state to fund a similar program for 2024.

Premier Roger Cook and Health Minister Amber-Jade Sanderson announced the funded program yesterday, urging residents to get their vaccine.

PSA Western Australia President Kristian Ray MPS also encouraged the community to access their vaccine ahead of the flu season.

“Removing cost barriers and giving West Australians greater access to vaccines through community pharmacies is a welcome first step to improving vaccine uptake,” Mr Ray said.

“It’s easy to become complacent and not keep up with annual flu shots, but immunisation remains the best protection against severe influenza.

“In 2023 we only saw 32 per cent of eligible people in Western Australia get their vaccine, this year we are hoping that figure will be much higher.

“I strongly urge all West Australians to speak to their pharmacist about the influenza vaccine and whether its appropriate for you and your family this flu season,” Mr Ray concluded.

 

Free influenza vaccines for all Western Australians will be available from community pharmacists, general practitioners and Aboriginal Health Services during the months of May and June.

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

WA women to have access to UTI care through pharmacists

4 August 2023

 

The Pharmaceutical Society of Australia (PSA) welcomes the West Australian Government’s commitment to improving access to care for thousands of women suffering from urinary tract infections each year.

 

From today, 4 August 2023, pharmacists who have undergone specific training will be able to prescribe antibiotics for uncomplicated urinary tract infections (UTIs) in patients aged 18 to 65 years old. The training is now available to all WA pharmacists.

 

PSA Western Australia President Kristian Ray welcomed the move, saying that patient’s access to care should be front of mind.

 

“Pharmacists are well positioned to play a greater role in primary health care and will make UTI treatments more accessible for more West Australians,” Mr Ray said.

 

“There are hundreds of thousands of women living in Western Australia that will benefit from this policy, particularly in rural and remote WA where there are significant barriers to accessing timely care.

 

“This program is about improving access to care where it is clinically appropriate, and working with the rest of the primary care team to promote a collaborative care model for Western Australians.

 

“There are robust referral pathways in place for patients who suffer from recurring UTIs, or might fall outside of the clinical inclusion criteria.

 

“As some of the most accessible healthcare professionals, pharmacists play a vital role in supporting the health and wellbeing of our communities.

 

“As pharmacists, we are committed to working collaboratively with the entire health sector to deliver best outcomes for patients.

 

“I am looking forward to working closely with the Government to ensure the success of the program, improving access to safe, timely care,” Mr Ray concluded.

 

The PSA training program Managing Uncomplicated Cystitis (Urinary Tract Infection) is now available to all WA pharmacists. More information is available here.

 

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au